Skip to content

Asset turnover at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
0.6×-0.1×
Avanos Medical logo
Avanos MedicalAVNS
0.7×+0.2×
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
0.5×+0.1×
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
0.5×0.0×
Theravance Biopharma logo
Theravance BiopharmaTBPH
0.3×+0.1×

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Calculated from Collegium Pharmaceutical, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s asset turnover?
Collegium Pharmaceutical, Inc. (COLL) reported asset turnover of 0.5× in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s asset turnover changed year-over-year?
Collegium Pharmaceutical, Inc.'s asset turnover increased by 0.2% year-over-year, from 0.5× to 0.5×.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s asset turnover?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s asset turnover has grown at a -6.3% compound annual growth rate (CAGR), from 0.7× to 0.5×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.